Intravitreal Injections

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
Eye Diseases "Treated" with Interoperable Medical InformaticsN/A1 trial
Active Trials
NCT06810011RecruitingEst. Feb 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
T-TherapeuticsEye Diseases "Treated" with Interoperable Medical Informatics

Clinical Trials (1)

NCT06810011T-TherapeuticsEye Diseases "Treated" with Interoperable Medical Informatics

Eye Diseases "Treated" with Interoperable Medical Informatics

Start: Mar 2024Est. completion: Feb 2028
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space